AB Science Corporate Presentation
22/07/2019 – AB Science Corporate Presentation – July 2019
Summary of the webconference held on July 8, 2019
09/07/2019 – AB Science is providing a summary of the web conference held on July 8, 2019
July 8 2019 web conference presentation
08/07/2019 – AB Science web conference presentation
Publication of the positive phase 2/3 clinical trial with masitinib in ALS in the journal ALSFD
08/07/2019 – AB Science announces the publication of the positive phase 2/3 clinical trial with masitinib in ALS in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
Validation of the AB8939 clinical development plan through regulatory authority Scientific Advice procedure
04/07/2019 – AB Science announces the European Medicine Agency has validated the clinical development program for its new compound AB8939 in acute myeloid leukemia (AML) through a Scientific Advice procedure.